IN2012DN00282A - - Google Patents

Info

Publication number
IN2012DN00282A
IN2012DN00282A IN282DEN2012A IN2012DN00282A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A IN 282DEN2012 A IN282DEN2012 A IN 282DEN2012A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A
Authority
IN
India
Prior art keywords
breast
compositions
infants
fed infants
nutritional supplement
Prior art date
Application number
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Isabelle Bureau-Franz
Clara Lucia Garcia-Rodenas
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00282A publication Critical patent/IN2012DN00282A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Birds (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
IN282DEN2012 2009-07-31 2010-07-28 IN2012DN00282A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31
PCT/EP2010/060973 WO2011012655A1 (fr) 2009-07-31 2010-07-28 Composition nutritionnelle pour nourrissons ou animaux de compagnie allaités comprenant des probiotiques et des nutriments sélectionnés

Publications (1)

Publication Number Publication Date
IN2012DN00282A true IN2012DN00282A (fr) 2015-05-08

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
IN282DEN2012 IN2012DN00282A (fr) 2009-07-31 2010-07-28

Country Status (14)

Country Link
US (1) US20120121562A1 (fr)
EP (1) EP2459202A1 (fr)
CN (1) CN102481323A (fr)
AU (1) AU2010277582A1 (fr)
BR (1) BR112012002223A2 (fr)
CA (1) CA2767960A1 (fr)
CL (1) CL2012000234A1 (fr)
IN (1) IN2012DN00282A (fr)
MX (1) MX2012001362A (fr)
RU (1) RU2012107695A (fr)
SG (1) SG177541A1 (fr)
TW (1) TW201117818A (fr)
WO (1) WO2011012655A1 (fr)
ZA (1) ZA201201471B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
CN103391783A (zh) 2010-12-31 2013-11-13 雅培制药有限公司 使用人乳寡糖改善呼吸道健康的方法
PH12013501382A1 (en) 2010-12-31 2013-09-02 Abbott Lab0Ratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CA3114006C (fr) 2010-12-31 2023-07-25 Abbott Laboratories Oligosaccharides de lait humain pour moduler l' inflammation
US9763970B2 (en) 2010-12-31 2017-09-19 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
CN102106463B (zh) * 2011-01-31 2012-12-05 杨永浩 一种微生物饲料添加剂及其制备方法
CN103347405A (zh) * 2011-02-10 2013-10-09 雀巢产品技术援助有限公司 使用人乳中发现的寡糖的组合调节双歧杆菌属的生长
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
EP2750523A1 (fr) 2011-08-29 2014-07-09 Abbott Laboratories Oligosaccharides de lait humain pour prévenir une lésion et/ou activer la guérison du tractus gastro-intestinal
MX350435B (es) * 2011-10-18 2017-09-06 Nestec Sa Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor.
ES2666491T5 (en) * 2011-10-18 2025-10-27 Nestle Sa Composition for use in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US9987306B2 (en) 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2015148384A1 (fr) 2014-03-26 2015-10-01 Abbott Laboratories Poudre de complément nutritionnel
WO2015176229A1 (fr) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Compositions nutritionnelles de synthèse spécifiques au mode d'accouchement et systèmes nutritionnels les comprenant
RU2731067C2 (ru) * 2015-03-05 2020-08-28 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
WO2016183535A1 (fr) 2015-05-14 2016-11-17 University Of Puerto Rico Procédé de restauration du microbiote de nouveau-nés
CN105030843A (zh) * 2015-06-18 2015-11-11 陈英扬 罗伊氏乳杆菌滴剂及其制备方法
EP3344268A1 (fr) * 2015-08-31 2018-07-11 Nestec S.A. Procédés et compositions utilisant du bifidobacterium longum pour moduler une réactivité émotionnelle et traiter ou prévenir des troubles de l'humeur subcliniques
FI3389407T3 (fi) 2015-12-14 2024-01-17 Nestle Sa Ravintokoostumus ja äidinmaidonkorvike de novo myelinaation edistämiseksi
WO2017117142A1 (fr) 2015-12-28 2017-07-06 New York University Dispositif et procédé de restauration du microbiote chez les nouveau-nés
WO2017151540A1 (fr) 2016-02-29 2017-09-08 Abbott Laboratories Complément alimentaire en poudre
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
EP3629770A1 (fr) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprenant de l'oligofructose (of) destinée à être utilisée dans l'amélioration de la mémoire à court terme et d'autres avantages cognitifs
WO2019002607A1 (fr) * 2017-06-30 2019-01-03 N.V. Nutricia Composition symbiotique pour la prévention de troubles
EP3672600A4 (fr) 2017-08-21 2021-05-19 Glycom A/S Composition synthétique pour réduire les symptômes d'allergie
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
EP3833195A1 (fr) * 2018-08-08 2021-06-16 Mars Incorporated Produits alimentaires pour animaux de compagnie comprenant des oligosaccharides et procédés d'utilisation
AU2019410036A1 (en) * 2018-12-21 2021-06-03 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
EP3920723A1 (fr) * 2019-02-04 2021-12-15 N.V. Nutricia Préparation pour nourrissons fermentée avec des oligosaccharides non digestibles pour l'amélioration du sommeil
KR102188765B1 (ko) * 2019-06-12 2020-12-08 정옥숙 애완동물용 동결건조파우더 및 이의 제조방법
US20220409679A1 (en) * 2019-11-29 2022-12-29 Societe Des Produits Nestle S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CN112868800A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 含母乳低聚糖提高免疫力的婴幼儿配方奶粉及其制备方法
MX2024003880A (es) * 2021-09-28 2024-04-22 Nestle Sa Composiciones para el uso.
US12527342B2 (en) * 2024-01-12 2026-01-20 Nutifood Nutrition Food Joint Stock Company Supplementary composition containing 2′-fucosyllactose (2′-fl) and fructo-oligosaccharide (FOS) with synergistic effects on the digestive and immune systems for children, and process of manufacturing a children formula containing said supplementary composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (fr) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
WO2003020048A1 (fr) * 2001-08-31 2003-03-13 Nutricopia, Inc. Dessert glace nutritionnel et procedes de fabrication associes
PL1638414T3 (pl) * 2003-06-23 2009-12-31 Nestec Sa Mleko modyfikowane niemowlęce lub następne
NZ544642A (en) * 2003-06-23 2009-01-31 Nestec Sa Infant or follow-on formula
JP2008500271A (ja) * 2003-10-14 2008-01-10 ザ・プロウボウスト・フェロウズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン・エリザベス・ニア・ダブリン 免疫介在性疾患の治療および／または予防におけるアデニル酸シクラーゼ
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
AU2006217160B2 (en) * 2005-02-28 2011-09-15 N.V. Nutricia Nutritional composition with probiotics
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
CA2624921C (fr) * 2005-10-05 2012-07-10 Nestec S.A. Formulation nutritionnelle favorisant la croissance de rattrapage
HUE041593T2 (hu) * 2006-03-29 2019-05-28 Nestec Sa Probiotikumokat tartalmazó táplálék-kiegészítõk
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974734A1 (fr) * 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour la réduction du risque d'obésité
EP1974743A1 (fr) * 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour l'amélioration du microbiote intestinal
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
MX2010006650A (es) * 2007-12-17 2010-09-28 Univ Florida Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
MX2011002983A (es) * 2008-09-19 2011-04-11 Nestec Sa Soporte nutricional para prevenir o moderar la paralisis de medula osea o neutropenia durante el tratamiento anti-cancer.

Also Published As

Publication number Publication date
AU2010277582A1 (en) 2012-02-02
SG177541A1 (en) 2012-02-28
EP2459202A1 (fr) 2012-06-06
WO2011012655A1 (fr) 2011-02-03
CL2012000234A1 (es) 2012-09-28
CN102481323A (zh) 2012-05-30
US20120121562A1 (en) 2012-05-17
ZA201201471B (en) 2014-08-27
CA2767960A1 (fr) 2011-02-03
BR112012002223A2 (pt) 2016-06-07
RU2012107695A (ru) 2013-09-10
MX2012001362A (es) 2012-02-22
TW201117818A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
IN2012DN00282A (fr)
MY164674A (en) Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
MY173382A (en) Infant feeding formulas comprising probiotic micro-organisms
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
IN2014CN04773A (fr)
MY161548A (en) Nutritional supplements for 50+individuals for improving vitality, immunity, eye and bone health
IN2012DN00713A (fr)
PH12013500739A1 (en) Array of age-tailored nutritional formula with probiotics
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
PH12015501688A1 (en) Nutritional compositions containing magnesium threonate and uses thereof
IN2013DN03771A (fr)
MY175195A (en) Nutritional compositions
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
PH12018500988A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
NZ612586A (en) Food containing milk ceramide, and process for production thereof
SG149718A1 (en) Cordyceps extract as a dietary supplement and uses thereof
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
MX2013006741A (es) Composicones a base de arcilla y polen de abeja, su proceso de preparacion y su uso nutricional y terapeutico.
PH12018500890A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PT2477503E (pt) Processo de preparação de um produto lácteo pasteurizado e fermentado, suplementado com cálcio e vitamina d
CN105454817A (zh) 一种补钙食品
UA66633U (ru) Состав мороженого молочно-пшеничного